Know Your Myeloma Therapy: Pomalyst (Pomalidomide) image

Know Your Myeloma Therapy: Pomalyst (Pomalidomide)

Sep 13, 2022
07:00PM - 08:00PM EDT
Online Event
Overview

Pomalidomide is a familiar myeloma therapy, but perhaps one that isn't as frequently used. Learn its mechanism of action, efficacy and side effects from Dr. Suvannasankha and come with your questions.

Agenda
07:00 PM
Introduction
Audrey Burton-Bethke
Audrey introduces the agenda of the event and featured speaker Dr. Attaya Suvannasankha
07:05 PM
Presentation
Attaya Suvannasankha, MD
Dr. Suvannasankha talks about Pomalidomide, its mechanism of action, efficacy and side effects
07:35 PM
Questions and Answers
Audience
Type your questions in the chat and we will answer them!
Speakers & Moderators
Healthtree contact Audrey Burton-Bethke

Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.
Healthtree contact Attaya Suvannasankha, MD

Attaya Suvannasankha, MD

Dr. Suvannasankha is a graduate of Chulalongkorn University in Thailand. She completed her residency at Albert Einstein Medical Center in Philadelphia and a fellowship at Roswell Park Comprehensive Cancer Center in Buffalo, New York. She joined the Indiana University School of Medicine in 2003 and currently serves as an associate professor at the IU School of Medicine and researcher at the IU Simon Comprehensive Cancer Center. Dr. Suvannasankha’s research interests are in the molecular mechanism of drug resistance in hematologic malignancy and precision medicine. Her clinical expertise includes hematology-oncology and bone marrow transplant.